Free cold-chain shipping on every orderDoctor formulated · Clinically studied strainsCFU guaranteed at expiry, not at manufactureSubscribe & save 15% — skip or cancel anytimeFree cold-chain shipping on every orderDoctor formulated · Clinically studied strainsCFU guaranteed at expiry, not at manufactureSubscribe & save 15% — skip or cancel anytime
Lorbiotics · LPB-CV-001
Clinical DomainCardiometabolic

Lorbiotics Cardi Forte

Heart health support that goes beyond diet and exercise. Probiotic strains that help manage cholesterol and triglyceride levels at the gut-microbiome level.

☆☆☆☆☆No reviews yet
6 Billion CFUTotal live cultures
6Active strains
Capsule / SachetDosage form
  • Capsules
  • Allergen Free
  • In Vitro Test
  • Clinical Test
  • 24 Month Stability
1
50%
The headline result

Up to 50% reduction in intestinal cholesterol absorption with Phytosterols 800 mg (EFSA/FDA approved) — combined with BSH-mediated LDL-C diversion and CLA production for comprehensive dyslipidaemia control.

The science

Why Cardi Forte works.

Lorpro-Cardiforte is a targeted cardiometabolic synbiotic designed to manage dyslipidaemia (elevated cholesterol and triglycerides) via the gut–heart axis.

It combines three Bifidobacterium strains (B. lactis, B. bifidum, B. longum) with Choline and Phytosterols to deliver a multi-pathway approach to lipid normalisation.

This complements diet and medication while supporting hepatic lipid metabolism and reducing intestinal cholesterol absorption.

Key Mechanisms

Probiotic BSH Activity: The Bifidobacterium strains produce bile salt hydrolase (BSH), which deconjugates bile salts in the gut. This reduces bile acid reabsorption, prompting the liver to use circulating cholesterol to produce new bile acids - effectively lowering serum LDL-C.

Bifidobacterium longum reduces triglycerides by generating propionate (a short-chain fatty acid) that inhibits hepatic de novo lipogenesis. Propionate competitively blocks acetyl-CoA utilization, suppressing fatty acid synthesis and VLDL-triglyceride production.

Additionally, these strains convert dietary linoleic acid into conjugated linoleic acid (CLA) in the colon, which further lowers LDL-C and raises HDL-C.

Phytosterols: These cholesterol-like plant compounds competitively inhibit intestinal cholesterol absorption (by 30–50% at effective doses).

Both EFSA and FDA have approved health claims for phytosterol-mediated cholesterol reduction.

Together, the BSH-driven cholesterol diversion and phytosterol-blocked absorption create a synergistic dual-action effect that delivers greater lipid-lowering benefits than either component alone.

Therapeutic targets
  • 01
    LDL cholesterol reduction
  • 02
    Triglyceride control
  • 03
    CLA production
  • 04
    Cholesterol absorption inhibition
  • 05
    Hepatic lipid metabolism support
  • 06
    Complementary to statin therapy

Lorpro-Cardiforte is a targeted cardiometabolic synbiotic designed to manage dyslipidaemia (elevated cholesterol and triglycerides) via the gut–heart axis.

Lorbiotics Cardi Forte · Cardiometabolic
Mechanism of action

How it works, step by step.

The documented biological pathway — exactly how each component acts inside the body.

01

Probiotic BSH Activity: The Bifidobacterium strains produce bile salt hydrolase (BSH), which deconjugates bile salts in the gut. This reduces bile acid reabsorption, prompting the liver to use circulating cholesterol to produce new bile acids - effectively lowering serum LDL-C.

02

Bifidobacterium longum reduces triglycerides by generating propionate (a short-chain fatty acid) that inhibits hepatic de novo lipogenesis. Propionate competitively blocks acetyl-CoA utilization, suppressing fatty acid synthesis and VLDL-triglyceride production.

03

Additionally, these strains convert dietary linoleic acid into conjugated linoleic acid (CLA) in the colon, which further lowers LDL-C and raises HDL-C.

04

Phytosterols: These cholesterol-like plant compounds competitively inhibit intestinal cholesterol absorption (by 30–50% at effective doses).

05

Both EFSA and FDA have approved health claims for phytosterol-mediated cholesterol reduction.

06

Together, the BSH-driven cholesterol diversion and phytosterol-blocked absorption create a synergistic dual-action effect that delivers greater lipid-lowering benefits than either component alone.

Inside the formula

Every ingredient earns its place.

The exact composition of Lorbiotics Cardi Forte — each organism and active listed at its formulated dose.

Composition · Lorbiotics Cardi ForteLPB-CV-001
Organism / activeDocumented roleDose
Bifidobacterium lactis5 B CFU
Bifidobacterium bifidum5 B CFU
Bifidobacterium longum5 B CFU
Cholineas standardized
Phytosterols800 mg
Total live cultures6 Billion CFU
The practical bits

How to take it.

Dosage

1–2 sachets/capsules daily, taken with the main meal containing dietary fat. For optimal lipid-lowering benefit: minimum 8-week course with lipid panel monitoring. Can be used as adjunct to statin or fibrate therapy. Or as advised by physician.

In the pack

Capsule / Sachet · 60 per Pack

With Choline and Phytosterols 800 mg (EFSA/FDA health claim). Take with fat-containing meal for optimal absorption.

Certifications

  • WHO-GMP
  • ISO 13485
  • Allergen Free
  • Clinical Test
  • 24 Month Stability
Note: Not for medicinal use or for curative action. Recommended to use as food supplement only
Reviews

What people say after they've actually taken it.

☆☆☆☆☆No reviews yet
☆☆☆☆☆

No reviews yet

Reviews come from verified buyers only. Once customers who've purchased Cardi Forte share their experience, you'll see it here.

Evidence base

Peer-reviewed references.

Every claim on this page traces back to published literature. The full citation list for Lorbiotics Cardi Forte.

  1. 01Nguyen TT. J Nutr. 1999 129(12):2109-12.
  2. 02Fuentes F, et al. Am J Clin Nutr. 2001 73(3):422-7.
  3. 03Probiotical S.p.A. LPB-CM-CARDIFORTE · B. lactis + B. bifidum + B. longum 6B + Choline + Phytosterols 800mg · 60 Caps
Often paired with

What people stack with this formula.